Omalizumab (anti-IgE)
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research.
| Trivial name | Olizumab, rhuMab-E25 |
| Catalog Number | A2044 |
| CAS# | 242138-07-4 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/omalizumab-anti-ige.html |